ArticleBMC neurology2026

Exacerbation of myasthenia gravis after zoledronic acid and denosumab: a novel clinical observation with therapeutic implications.

Stefania Canneva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.